Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids

BACKGROUND: The clinical guideline recommends use of long-acting β2 agonists/long-acting muscarinic antagonists (LABA/LAMA) or long-acting β2 agonists/inhaled corticosteroids (LABA/ICS) combination therapies for patients with severe chronic obstructive pulmonary disease (COPD). The fixed-dose combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Pei-An, Pan, Sheng-Wei, Chen, Chun-Yu, Deng, Chung-Yeh, Dong, Yaa-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105570/
https://www.ncbi.nlm.nih.gov/pubmed/37069844
http://dx.doi.org/10.2147/COPD.S393392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105570/
https://www.ncbi.nlm.nih.gov/pubmed/37069844
http://dx.doi.org/10.2147/COPD.S393392

Ejemplares similares